Angela A. Velasquez

Araraquara, SP 14800060, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Evaluation of Antileishmanial and Antibacterial Activity of Bioconjugate Guanidine-Temporin.

Evaluation of Antileishmanial and Antibacterial Activity of Bioconjugate Guanidine-Temporin.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 13, 2026

Calcium homeostasis in trypanosomatids: A review of molecular targets and inhibitors.

Calcium homeostasis in trypanosomatids: A review of molecular targets and inhibitors.

Journal: Cell calcium

Published: July 24, 2025

Surface molecules of Leishmania: From virulence determinants to therapeutic and vaccine targets.

Surface molecules of Leishmania: From virulence determinants to therapeutic and vaccine targets.

Journal: Molecular and biochemical parasitology

Published: July 18, 2025

Guanidines Conjugated with Cell-Penetrating Peptides: A New Approach for the Development of Antileishmanial Molecules.

Guanidines Conjugated with Cell-Penetrating Peptides: A New Approach for the Development of Antileishmanial Molecules.

Journal: Molecules (Basel, Switzerland)

Published: November 29, 2024

Peptide Dimerization as a Strategy for the Development of Antileishmanial Compounds.

Peptide Dimerization as a Strategy for the Development of Antileishmanial Compounds.

Journal: Molecules (Basel, Switzerland)

Published: October 08, 2024

Advances in Cysteine Protease B Inhibitors for Leishmaniasis Treatment.

Advances in Cysteine Protease B Inhibitors for Leishmaniasis Treatment.

Journal: Current drug targets

Published: May 20, 2024

Antileishmanial activity of tetra-cationic porphyrins with peripheral Pt(II) and Pd(II) complexes mediated by photodynamic therapy.

Antileishmanial activity of tetra-cationic porphyrins with peripheral Pt(II) and Pd(II) complexes mediated by photodynamic therapy.

Journal: Photodiagnosis and photodynamic therapy

Published: January 26, 2023

New Insights into the Mechanism of Action of the Cyclopalladated Complex (CP2) in Leishmania: Calcium Dysregulation, Mitochondrial Dysfunction, and Cell Death.

New Insights into the Mechanism of Action of the Cyclopalladated Complex (CP2) in Leishmania: Calcium Dysregulation, Mitochondrial Dysfunction, and Cell Death.

Journal: Antimicrobial agents and chemotherapy

Published: October 11, 2021

Antileishmanial activity of amphiphilic chlorin derivatives mediated by photodynamic therapy.

Antileishmanial activity of amphiphilic chlorin derivatives mediated by photodynamic therapy.

Journal: Photodiagnosis and photodynamic therapy

Published: January 22, 2020

N, N', N″-trisubstituted guanidines: Synthesis, characterization and evaluation of their leishmanicidal activity.

N, N', N″-trisubstituted guanidines: Synthesis, characterization and evaluation of their leishmanicidal activity.

Journal: European journal of medicinal chemistry

Published: February 12, 2019

Potential application of rLc36 protein for diagnosis of canine visceral leishmaniasis.

Potential application of rLc36 protein for diagnosis of canine visceral leishmaniasis.

Journal: Memorias do Instituto Oswaldo Cruz

Published: April 27, 2017

Efficacy of a Binuclear Cyclopalladated Compound Therapy for Cutaneous Leishmaniasis in the Murine Model of Infection with Leishmania amazonensis and Its Inhibitory Effect on Topoisomerase 1B.

Efficacy of a Binuclear Cyclopalladated Compound Therapy for Cutaneous Leishmaniasis in the Murine Model of Infection with Leishmania amazonensis and Its Inhibitory Effect on Topoisomerase 1B.

Journal: Antimicrobial agents and chemotherapy

Published: April 03, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026